Join the fastest growing community of drug discovery innovators
Cut through the noise and find breakthroughs. Expertly researched & curated content makes keeping up with the literature easy.
Stay up-to-date and discover your next great idea – FREE.
By subscribing to our newsletter, you agree to our terms and conditions and privacy policy. Unsubscribe anytime.
be sure to whitelist the @drughunter.com domain in your e-mail inbox to make sure your free content doesn’t get sent to spam!
Testimonials
-
“Drug Hunter has a great overview of what is happening in our field, saves time on scouring through news feeds, literature and irrelevant stuff that comes up. It is a tool specifically for people like me to weed out the noise. Big time saver.”
Cyril Bucher
Drug Discovery Scientist, Denali Therapeutics / Publicly Listed Biotech
-
“I look forward to reading the summaries that come out every month. It helps me keep up to date on what’s going on in the industry.”
Hilary Beck
Senior Director, Head of Medicinal Chemistry, Eikon Therapeutics / VC-Backed Biotech
-
“When I need to find information, I know that I can find it on Drug Hunter. This is what was always missing in our field. I’ve been designing drugs for years and the most frustrating part is learning on your own. You may need to go through hundreds of articles to find the information you need. Drug Hunter cuts down on a lot of this!”
Berenger Biannic
Associate Director, Drug Discovery, Essa Pharma / Publicly Listed Biotech
-
“Drug Hunter helps keep me up to date with the scientific literature and saves me so much valuable time. Please continue the excellent work!”
Vincent Guerlavais
Senior Director of Medicinal Chemistry, Protagonist Therapeutics / Publicly Listed Biotech
-
“The thing I like most about it is the concise, to-the-point presentation of the relevant information in an easily digestible format, that is readily accessible to all, from experienced drug hunters to scientists who are just starting their careers. The time-savings achieved by using Drug Hunter are another major selling point. Keep up the good work, folks!”
David Barrett
Executive Director, Science and Strategy Advisor, Astellas Pharma
-
“I like Drug Hunter! I realize that the team puts so much time and effort into this work and it is not easy work. It is a key opinion leader in the industry. I want Drug Hunter to go on forever. It’s really good!”
Mark Baik
Founder and CEO, Arum Therapeutics / Privately Held Biotech
-
“The cheat sheets that are published are great. Having a centralized resource of those is super helpful. When I recently onboarded a new team member, I taught her about Topliss trees using Drug Hunter. I am way more on top of the med. chem literature because of Drug Hunter!”
Benjamin Horning
Senior Scientist, Medicinal Chemistry, Vividion Therapeutics
-
“I don’t know of anything similar to this. It’s great that I can visit the site and get a pointer to recent important papers in the field. With the article annotations, I also get a perspective I may not get just by reading papers myself.”
Matthew Robinson
Computational Chemist, PostEra
-
“I know I can find new information, targets, and compounds on Drug Hunter each month, which has been really helpful. It’s a good website to see the latest news in drug discovery!”
TJ Bing
Senior Group Leader, Pharmaron
-
“Drug Hunters highly informed, relevant science, category-leading approach is time saving, cost saving and importantly a consistent source of inspiration for new Product Development programs. More like this please Drug Hunter!”
Trevor Brett
Director of Business Development, Pharmalex
-
“I like that Drug Hunter shows condensed information about what is at the forefront of medicinal chemistry at the moment. The molecules are great, I would otherwise have to sift through a lot of articles to find these drugs. I am very satisfied with Drug Hunter.”
Grant Shibuya
Medicinal Chemist, RAPT Therapeutics / Publicly Listed Biotech
-
As both an academic and (most recently) an industrial medicinal chemist, the Drug Hunter resources have been very helpful so far. I’ve passed along several of the excellent primer/cheat sheets to my own students, and the lists of CROs and investors have been helpful for company building. Of course, the Molecules of the Month, and the deep science and strategy behind their structures shared in…
Chris Dockendorff
Academic, Industrial Chemist
Join Subscribers from
RECENT ARTICLES
- 2022 Molecules of the Year: Nominate!
- First-in-Class Large Molecule Drug Approvals of 2022
- First-in-Class Small Molecule Drug Approvals of 2022
- 2022 Novel Large Molecule Drug Approvals
- 2022 Novel Small Molecule Drug Approvals
- Molecules of the Month – December 2022
Drug Discovery Resources
- Drug Discovery Resources
- Drug Discovery Posters and Cheat Sheets
- Drug Discovery IPOs and Industry Reviews
- Lists of Approved Drugs
- Classics in Drug Discovery
- Drug Discovery Books
- Drug Discovery Conferences
- What is a Drug Hunter?
- Topliss Tree and Topliss Scheme Posters
- PK Reference Table / Cheat Sheet
- Pd-Couplings Table / Cheat Sheet